Arnold & Porter
Client SatisfactionArnold & Porter takes on the spectrum of antitrust disputes, handling class actions concerning price fixing, monopolization and a variety of exclusionary conduct allegations for clients in the pharmaceuticals and publishing fields, among others. Heading the firm’s global antitrust group is Debbie Feinstein, who offers experience in liaising with and litigating against competition authorities including the FTC on behalf of industries including pharma, food and retail, while Jonathan Gleklen heads the US-based practice, specializing in the high-tech and network sectors and representing clients in civil antitrust litigation. Laura Shores counts a number of well-known pharma companies among her clients and maintains a practice that covers both civil and criminal antitrust litigation, including matters arising out of patent licensing agreements and price fixing. Anne Davis acts for clients in class actions, opt-out litigation and government investigations arising out of monopolization, price fixing and exclusive dealing allegations. All named lawyers are based in Washington DC.
Key clients
- AstraZeneca Pharmaceuticals LP
- Bausch Health Companies
- Bayer/Elanco Animal Health
- Bristol-Myers Squibb
- Bayer/Bayer Crop Science
- Oakland Raiders
- Mallinckrodt
- Sandoz Inc./Fougera Pharmaceuticals Inc.
- University of Chicago
- Visa
- Norfolk Southern Corporation
- HarperCollins Publishers Inc.
- Mallinckrodt
- Nucor
- Celgene
- Penguin Random House
- GTL
Work highlights
- Represented HarperCollins in various antitrust actions involving the pricing of e-books, as well as in private class action and retailer litigation brought against various publishers and Apple as well as Amazon.
- Represented the Oakland Raiders in antitrust litigation purporting to challenge the Raiders' relocation to Las Vegas.
- Represented Sandoz/Fougera Pharmaceuticals Inc. in multidistrict litigation involving several dozen direct and indirect purchaser class action complaints, as well as State Attorney General actions, alleging that generic manufacturers conspired to raise the prices of several different pharmaceutical products.
Practice head
The lawyer(s) leading their teams.
Debbie Feinstein, Jonathan Gleklen